$TMGI
Marquie Group, Inc. Stock $tmgi

$tmgi Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000168316824007249 Filed on October 21, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2024 Q2
Revenue		$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin			$177.1K
YoY Change			70.44%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$93.00	$140.00
YoY Change		-59.57%	-39.13%
% of Gross Profit
Operating Expenses		$60.64K	$177.1K
YoY Change		-21.8%	70.44%
Operating Profit		-$60.64K
YoY Change		-21.8%
Interest Expense			$251.6K
YoY Change			-42.17%
% of Operating Profit
Other Income/Expense, Net		-$144.3K
YoY Change		-133.51%
Pretax Income		-$204.9K	$74.51K
YoY Change		-158.04%	-77.5%
Income Tax		$0.00	$0.00
% Of Pretax Income			0.0%
Net Earnings		-$204.9K	$74.51K
YoY Change		-158.04%	-77.5%
Net Earnings / Revenue
Basic Earnings Per Share		$0.00
Diluted Earnings Per Share		$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	3.326B shares	3.888B shares	1.411B shares
Diluted Shares Outstanding		3.326B shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$0.00
YoY Change
Cash & Equivalents	$0.00	$0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$642.00	$735.00
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$0.00	$0.00
YoY Change	-100.0%
LONG-TERM ASSETS
Property, Plant & Equipment		$740.00
YoY Change		-20.43%
Goodwill
YoY Change
Intangibles	$11.17K	$11.17K
YoY Change	7.72%	7.72%
Long-Term Investments		$6.200M
YoY Change		0.0%
Other Assets	$6.247M	$6.247M
YoY Change	0.12%	0.12%
Total Long-Term Assets	$6.247M	$6.247M
YoY Change	0.12%	0.12%
TOTAL ASSETS
Total Short-Term Assets	$0.00	$0.00
Total Long-Term Assets	$6.247M	$6.247M
Total Assets	$6.247M	$6.247M
YoY Change	0.12%	0.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$77.07K	$77.07K
YoY Change	13.95%	52.13%
Accrued Expenses		$2.230M
YoY Change		29.38%
Deferred Revenue
YoY Change
Short-Term Debt		$3.517M
YoY Change		-1.09%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.236M	$6.031M
YoY Change	3.7%	-5.28%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.236M	$6.031M
Total Long-Term Liabilities		$0.00
Total Liabilities	$6.236M	$6.031M
YoY Change	3.7%	-5.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$15.07M	-$14.86M
YoY Change	5.04%	1.13%
Common Stock	$332.6K	$332.6K
YoY Change	339.52%	339.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.49K	$216.4K
YoY Change
Total Liabilities & Shareholders Equity	$6.247M	$6.247M
YoY Change	0.12%	0.12%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$204.9K	$74.51K
YoY Change	-158.04%	-77.5%
Depreciation, Depletion And Amortization	$93.00	$140.00
YoY Change	-59.57%	-39.13%
Cash From Operating Activities	-$546.00	$14.40K
YoY Change	62.02%	-119.43%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change		-100.0%
Cash From Investing Activities	$0.00	$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$546.00	-16.57K
YoY Change	20.26%	-120.96%
NET CHANGE
Cash From Operating Activities	-$546.00	14.40K
Cash From Investing Activities	$0.00	0.000
Cash From Financing Activities	$546.00	-16.57K
Net Change In Cash	$0.00	-2.170K
YoY Change	-100.0%	4240.0%
FREE CASH FLOW
Cash From Operating Activities	-$546.00	$14.40K
Capital Expenditures		$0.00
Free Cash Flow		$14.40K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--05-31
CY2024Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1385917	usd
CY2024Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	1434733	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6030701	usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	332555	usd
CY2024Q3	dei	Entity File Number EntityFileNumber	000-54163
CY2024Q3	dei	Entity Registrant Name EntityRegistrantName	The Marquie Group, Inc.
CY2024Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2024Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001434601
CY2024Q3	dei	Document Type DocumentType	10-Q
CY2024Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	dei	Document Period End Date DocumentPeriodEndDate	2024-08-31
CY2024Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-2091212
CY2024Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	7901 4th ST N
CY2024Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 4887
CY2024Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	St. Petersburg
CY2024Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2024Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33702
CY2024Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33702
CY2024Q3	dei	City Area Code CityAreaCode	800
CY2024Q3	dei	Local Phone Number LocalPhoneNumber	351-3021
CY2024Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q3	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3325531102	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	0	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	0	usd
CY2024Q3	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	6200000	usd
CY2024Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	6200000	usd
CY2024Q3	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	35237	usd
CY2024Q2	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	35237	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21626	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21533	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	642	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	735	usd
CY2024Q3	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	11165	usd
CY2024Q2	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	11165	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6247044	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6247137	usd
CY2024Q3	us-gaap	Assets Assets	6247044	usd
CY2024Q2	us-gaap	Assets Assets	6247137	usd
CY2024Q3	us-gaap	Bank Overdrafts BankOverdrafts	235	usd
CY2024Q2	us-gaap	Bank Overdrafts BankOverdrafts	89	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	77074	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	77074	usd
CY2024Q3	us-gaap	Interest Payable Current InterestPayableCurrent	931632	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	844460	usd
CY2024Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1445917	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	11808	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	31709	usd
CY2024Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	1454633	usd
CY2024Q3	TMGI	Notes Payable To Related Parties Current NotesPayableToRelatedPartiesCurrent	2082715	usd
CY2024Q2	TMGI	Notes Payable To Related Parties Current NotesPayableToRelatedPartiesCurrent	2082315	usd
CY2024Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	243346	usd
CY2024Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	206113	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6235552	usd
CY2024Q3	us-gaap	Liabilities Liabilities	6235552	usd
CY2024Q2	us-gaap	Liabilities Liabilities	6030701	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	200	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	200	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	200	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	200	shares
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3325531102	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3325531102	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	756612000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	756612000	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	332555	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14747367	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14747367	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15068430	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14863486	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	11492	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	216436	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6247044	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6247137	usd
CY2024Q3	us-gaap	Revenues Revenues	0	usd
CY2023Q3	us-gaap	Revenues Revenues	0	usd
CY2024Q3	us-gaap	Salaries And Wages SalariesAndWages	60000	usd
CY2023Q3	us-gaap	Salaries And Wages SalariesAndWages	60000	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	0	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	16976	usd
CY2024Q3	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	640	usd
CY2023Q3	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	567	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	60640	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	77543	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-60640	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-77543	usd
CY2024Q3	TMGI	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	-37232	usd
CY2023Q3	TMGI	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	543223	usd
CY2024Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	19900	usd
CY2023Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	24125	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	107072	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	112598	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-144304	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	430625	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-204944	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	353082	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-204944	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	353082	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3325531102	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3325531102	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	756612000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	756612000	shares
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	216436	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-204944	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	11492	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-127011	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	353082	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	226071	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-204944	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	353082	usd
CY2024Q3	us-gaap	Depreciation Depreciation	93	usd
CY2023Q3	us-gaap	Depreciation Depreciation	230	usd
CY2024Q3	TMGI	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	-37233	usd
CY2023Q3	TMGI	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	543223	usd
CY2024Q3	TMGI	Amortization Of Debt Discounts AmortizationOfDebtDiscounts	19900	usd
CY2023Q3	TMGI	Amortization Of Debt Discounts AmortizationOfDebtDiscounts	24125	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	0	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	16975	usd
CY2024Q3	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	87172	usd
CY2023Q3	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	88474	usd
CY2024Q3	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	60000	usd
CY2023Q3	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	60000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-546	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-337	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2024Q3	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	146	usd
CY2023Q3	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	-46	usd
CY2024Q3	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	400	usd
CY2023Q3	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	500	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	546	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	454	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	0	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	117	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117	usd
CY2024Q3	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2024Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2024Q3	TMGI	Working Capital WorkingCapital	6235552	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15068430	usd
CY2024Q3	us-gaap	Inventory Gross InventoryGross	22268	usd
CY2024Q2	us-gaap	Inventory Gross InventoryGross	22268	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21626	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21533	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	642	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	735	usd
CY2024Q3	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	0	usd
CY2024Q3	us-gaap	Depreciation Depreciation	93	usd
CY2023Q3	us-gaap	Depreciation Depreciation	230	usd
CY2024Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1445917	usd
CY2024Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1385917	usd
CY2024Q2	TMGI	Accrued Professional Fees Total Current AccruedProfessionalFeesTotalCurrent	1385917	usd
CY2023Q2	TMGI	Accrued Professional Fees Total Current AccruedProfessionalFeesTotalCurrent	1145917	usd
CY2024Q3	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	60000	usd
CY2024	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	240000	usd
CY2024Q3	TMGI	Payments To Consultants PaymentsToConsultants	0	usd
CY2024	TMGI	Payments To Consultants PaymentsToConsultants	0	usd
CY2024Q3	TMGI	Accrued Professional Fees Total Current AccruedProfessionalFeesTotalCurrent	1445917	usd
CY2024Q2	TMGI	Accrued Professional Fees Total Current AccruedProfessionalFeesTotalCurrent	1385917	usd
CY2024Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1454633	usd
CY2024Q2	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1434733	usd
CY2024Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	1454633	usd
CY2024Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	1434733	usd
CY2024Q3	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	0	usd
CY2024Q2	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	0	usd
CY2024Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	1466441	usd
CY2024Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	1466442	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	-11808	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	-31709	usd
CY2024Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1454633	usd
CY2024Q2	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1434733	usd
CY2024Q3	TMGI	Notes Payable Related Parties NotesPayableRelatedParties	2082715	usd
CY2024Q2	TMGI	Notes Payable Related Parties NotesPayableRelatedParties	2082315	usd
CY2024Q3	TMGI	Notes Payable To Related Parties Current NotesPayableToRelatedPartiesCurrent	2082715	usd
CY2024Q2	TMGI	Notes Payable To Related Parties Current NotesPayableToRelatedPartiesCurrent	2082315	usd
CY2024Q3	TMGI	Notes Payable To Related Parties Noncurrent NotesPayableToRelatedPartiesNoncurrent	0	usd
CY2024Q2	TMGI	Notes Payable To Related Parties Noncurrent NotesPayableToRelatedPartiesNoncurrent	0	usd
CY2024Q3	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	599738	usd
CY2024Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	243346	usd
CY2024Q2	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	599738	usd
CY2024Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	206113	usd
CY2024Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	243346	usd
CY2024Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	206113	usd
CY2024	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	2265475967	shares
CY2024	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	350472	usd
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001683168-24-007249-index-headers.html	Edgar Link	pending
0001683168-24-007249-index.html	Edgar Link	pending
0001683168-24-007249.txt	Edgar Link	pending
0001683168-24-007249-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tmgi-20240831.xsd	Edgar Link	pending
tmgi_ex3101.htm	Edgar Link	pending
tmgi-20240831_cal.xml	Edgar Link	unprocessable
tmgi-20240831_def.xml	Edgar Link	unprocessable
tmgi-20240831_lab.xml	Edgar Link	unprocessable
tmgi-20240831_pre.xml	Edgar Link	unprocessable
tmgi_ex3201.htm	Edgar Link	pending
tmgi_i10q-83124.htm	Edgar Link	pending
tmgi_i10q-83124_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TMGI
Marquie Group, Inc. Stock $tmgi

2024 Q4 Form 10-Q Financial Statement

#000168316824007249 Filed on October 21, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TMGI Marquie Group, Inc. Stock $tmgi

2024 Q4 Form 10-Q Financial Statement

#000168316824007249 Filed on October 21, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TMGI
Marquie Group, Inc. Stock $tmgi